Thibault Boutherin
Stock Analyst at Morgan Stanley
(0.58)
# 4,139
Out of 5,126 analysts
4
Total ratings
50%
Success rate
-12.7%
Average return
Main Sectors:
Stocks Rated by Thibault Boutherin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALVO Alvotech | Upgrades: Overweight | $14 | $5.12 | +173.44% | 2 | Oct 14, 2025 | |
| NVO Novo Nordisk | Downgrades: Underweight | $59 → $47 | $47.64 | -1.34% | 1 | Sep 29, 2025 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Equal-Weight | $10 | $34.69 | -71.17% | 1 | May 25, 2023 |
Alvotech
Oct 14, 2025
Upgrades: Overweight
Price Target: $14
Current: $5.12
Upside: +173.44%
Novo Nordisk
Sep 29, 2025
Downgrades: Underweight
Price Target: $59 → $47
Current: $47.64
Upside: -1.34%
Teva Pharmaceutical Industries
May 25, 2023
Initiates: Equal-Weight
Price Target: $10
Current: $34.69
Upside: -71.17%